Cargando…

Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro

Background: The use of alternative flame retardants has increased since the phase out of pentabromodiphenyl ethers (pentaBDEs). One alternative, Firemaster® 550 (FM550), induces obesity in rats. Triphenyl phosphate (TPP), a component of FM550, has a structure similar to that of organotins, which are...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillai, Hari K., Fang, Mingliang, Beglov, Dmitri, Kozakov, Dima, Vajda, Sandor, Stapleton, Heather M., Webster, Thomas F., Schlezinger, Jennifer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NLM-Export 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216168/
https://www.ncbi.nlm.nih.gov/pubmed/25062436
http://dx.doi.org/10.1289/ehp.1408111
_version_ 1782342227295469568
author Pillai, Hari K.
Fang, Mingliang
Beglov, Dmitri
Kozakov, Dima
Vajda, Sandor
Stapleton, Heather M.
Webster, Thomas F.
Schlezinger, Jennifer J.
author_facet Pillai, Hari K.
Fang, Mingliang
Beglov, Dmitri
Kozakov, Dima
Vajda, Sandor
Stapleton, Heather M.
Webster, Thomas F.
Schlezinger, Jennifer J.
author_sort Pillai, Hari K.
collection PubMed
description Background: The use of alternative flame retardants has increased since the phase out of pentabromodiphenyl ethers (pentaBDEs). One alternative, Firemaster® 550 (FM550), induces obesity in rats. Triphenyl phosphate (TPP), a component of FM550, has a structure similar to that of organotins, which are obesogenic in rodents. Objectives: We tested the hypothesis that components of FM550 are biologically active peroxisome proliferator-activated receptor γ (PPARγ) ligands and estimated indoor exposure to TPP. Methods: FM550 and its components were assessed for ligand binding to and activation of human PPARγ. Solvent mapping was used to model TPP in the PPARγ binding site. Adipocyte and osteoblast differentiation were assessed in bone marrow multipotent mesenchymal stromal cell models. We estimated exposure of children to TPP using a screening-level indoor exposure model and house dust concentrations determined previously. Results: FM550 bound human PPARγ, and binding appeared to be driven primarily by TPP. Solvent mapping revealed that TPP interacted with binding hot spots within the PPARγ ligand binding domain. FM550 and its organophosphate components increased human PPARγ1 transcriptional activity in a Cos7 reporter assay and induced lipid accumulation and perilipin protein expression in BMS2 cells. FM550 and TPP diverted osteogenic differentiation toward adipogenesis in primary mouse bone marrow cultures. Our estimates suggest that dust ingestion is the major route of exposure of children to TPP. Conclusions: Our findings suggest that FM550 components bind and activate PPARγ. In addition, in vitro exposure initiated adipocyte differentiation and antagonized osteogenesis. TPP likely is a major contributor to these biological actions. Given that TPP is ubiquitous in house dust, further studies are warranted to investigate the health effects of FM550. Citation: Pillai HK, Fang M, Beglov D, Kozakov D, Vajda S, Stapleton HM, Webster TF, Schlezinger JJ. 2014. Ligand binding and activation of PPARγ by Firemaster® 550: effects on adipogenesis and osteogenesis in vitro. Environ Health Perspect 122:1225–1232; http://dx.doi.org/10.1289/ehp.1408111
format Online
Article
Text
id pubmed-4216168
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher NLM-Export
record_format MEDLINE/PubMed
spelling pubmed-42161682014-11-10 Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro Pillai, Hari K. Fang, Mingliang Beglov, Dmitri Kozakov, Dima Vajda, Sandor Stapleton, Heather M. Webster, Thomas F. Schlezinger, Jennifer J. Environ Health Perspect Research Background: The use of alternative flame retardants has increased since the phase out of pentabromodiphenyl ethers (pentaBDEs). One alternative, Firemaster® 550 (FM550), induces obesity in rats. Triphenyl phosphate (TPP), a component of FM550, has a structure similar to that of organotins, which are obesogenic in rodents. Objectives: We tested the hypothesis that components of FM550 are biologically active peroxisome proliferator-activated receptor γ (PPARγ) ligands and estimated indoor exposure to TPP. Methods: FM550 and its components were assessed for ligand binding to and activation of human PPARγ. Solvent mapping was used to model TPP in the PPARγ binding site. Adipocyte and osteoblast differentiation were assessed in bone marrow multipotent mesenchymal stromal cell models. We estimated exposure of children to TPP using a screening-level indoor exposure model and house dust concentrations determined previously. Results: FM550 bound human PPARγ, and binding appeared to be driven primarily by TPP. Solvent mapping revealed that TPP interacted with binding hot spots within the PPARγ ligand binding domain. FM550 and its organophosphate components increased human PPARγ1 transcriptional activity in a Cos7 reporter assay and induced lipid accumulation and perilipin protein expression in BMS2 cells. FM550 and TPP diverted osteogenic differentiation toward adipogenesis in primary mouse bone marrow cultures. Our estimates suggest that dust ingestion is the major route of exposure of children to TPP. Conclusions: Our findings suggest that FM550 components bind and activate PPARγ. In addition, in vitro exposure initiated adipocyte differentiation and antagonized osteogenesis. TPP likely is a major contributor to these biological actions. Given that TPP is ubiquitous in house dust, further studies are warranted to investigate the health effects of FM550. Citation: Pillai HK, Fang M, Beglov D, Kozakov D, Vajda S, Stapleton HM, Webster TF, Schlezinger JJ. 2014. Ligand binding and activation of PPARγ by Firemaster® 550: effects on adipogenesis and osteogenesis in vitro. Environ Health Perspect 122:1225–1232; http://dx.doi.org/10.1289/ehp.1408111 NLM-Export 2014-07-25 2014-11 /pmc/articles/PMC4216168/ /pubmed/25062436 http://dx.doi.org/10.1289/ehp.1408111 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, “Reproduced with permission from Environmental Health Perspectives”); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Pillai, Hari K.
Fang, Mingliang
Beglov, Dmitri
Kozakov, Dima
Vajda, Sandor
Stapleton, Heather M.
Webster, Thomas F.
Schlezinger, Jennifer J.
Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title_full Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title_fullStr Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title_full_unstemmed Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title_short Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
title_sort ligand binding and activation of pparγ by firemaster(®) 550: effects on adipogenesis and osteogenesis in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216168/
https://www.ncbi.nlm.nih.gov/pubmed/25062436
http://dx.doi.org/10.1289/ehp.1408111
work_keys_str_mv AT pillaiharik ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT fangmingliang ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT beglovdmitri ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT kozakovdima ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT vajdasandor ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT stapletonheatherm ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT websterthomasf ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro
AT schlezingerjenniferj ligandbindingandactivationofppargbyfiremaster550effectsonadipogenesisandosteogenesisinvitro